From owner-chromosomes@net.bio.net Wed Dec 01 22:00:00 1993
Path: biosci!CS.Arizona.EDU!organpipe.uug.arizona.edu!uunet!cs.utexas.edu!howland.reston.ans.net!europa.eng.gtefsd.com!library.ucla.edu!network.ucsd.edu!clinical-mac-95.ucsd.edu!user
From: dkolk@popmail.ucsd.edu (Dan Kolk)
Newsgroups: bionet.genome.chromosomes
Subject: Re: Chromosome 1q
Message-ID: <dkolk-021293121149@clinical-mac-95.ucsd.edu>
Date: 2 Dec 93 15:11:49 GMT
Followup-To: bionet.genome.chromosomes
Organization: UCSD School of Medicine
Lines: 2
NNTP-Posting-Host: clinical-mac-95.ucsd.edu

Thank to all who responded to my chromosome 1 request.  I have registered
with the GDB.

From owner-chromosomes@net.bio.net Fri Dec 03 22:00:00 1993
Path: biosci!daresbury!doc.ic.ac.uk!pipex!howland.reston.ans.net!darwin.sura.net!news-feed-1.peachnet.edu!concert!rutgers!princeton!phoenix.Princeton.EDU!harnad
From: harnad@phoenix.Princeton.EDU (Stevan Harnad)
Newsgroups: bionet.neuroscience,bionet.cellbiol,bionet.molbio.ageing,bionet.genome.chromosomes
Subject: Neural Transplantation: Call for Commentators
Keywords: neural grafts, gene therapy, brain damage, functional recovery
Message-ID: <1993Dec2.224215.21986@Princeton.EDU>
Date: 2 Dec 93 22:42:15 GMT
Sender: news@Princeton.EDU (USENET News System)
Organization: Princeton University
Lines: 222
Xref: biosci bionet.neuroscience:2127 bionet.cellbiol:197 bionet.molbio.ageing:578 bionet.genome.chromosomes:117
Originator: news@nimaster
Nntp-Posting-Host: phoenix.princeton.edu

BBS Special Issue CONTROVERSIES IN NEUROSCIENCE II: Neural Transplantation

Below are the abstracts of 3 forthcoming target articles for a special
issue on Neural Transplantation that will appear in Behavioral and Brain
Sciences (BBS), an international, interdisciplinary journal that
provides Open Peer Commentary on important and controversial current
research in the biobehavioral and cognitive sciences. This will be the
second in a new series called "Controversies in Neuroscience,"
undertaken in collaboration with Paul Cordo and the RS Dow Neurological
Science Institute.

Commentators must be current BBS Associates or nominated by a current
BBS Associate. To be considered as a commentator on any of these
articles, to suggest other appropriate commentators, or for information
about how to become a BBS Associate, please send email to:
harnad@clarity.princeton.edu  or harnad@pucc.bitnet        or write to:
BBS, 20 Nassau Street, #240, Princeton NJ 08542  [tel: 609-921-7771]

Please specify which article or articles you would like to comment on.
(Commentators are allotted 1000 words to comment on one article, 1750
words to comment on two, and a maximum of 2250 words to comment on all
three target articles.) To help us put together a balanced list of
commentators, please give some indication of the aspects of the topic
on which you would bring your areas of expertise to bear if you were
selected as a commentator.

Within the next week or so, electronic drafts of the full text of each
article will be available for inspection by anonymous ftp, archie,
gopher or versonica on host princeton.edu directory pub/harnad/BBS
according to the instructions that follow after the abstracts. These
drafts are for inspection only; please do not prepare a commentary
until you are formally invited to do so.

1. NEURAL TRANSPLANTATION AND RECOVERY OF COGNITIVE FUNCTION
   John D. Sinden, Helen Hodges & Jeffrey A. Gray
   Filename: bbs.sinden

2. FETAL BRAIN TISSUE GRAFTS AS THERAPY FOR BRAIN DYSFUNCTIONS
   Donald G. Stein & Marylou M. Glasier
   Filename: bbs.stein
   
3. GENE REPLACEMENT THERAPY IN THE CENTRAL NERVOUS SYSTEM
   Edward A.Neuwelt, Michael A. Pagel, Leslie L. Muldoon & Alfred Geller
   Filename: bbs.neuwelt

---------------------------------------------------------------------
1.
        NEURAL TRANSPLANTATION AND RECOVERY OF COGNITIVE FUNCTION

            John D. Sinden, Helen Hodges & Jeffrey A. Gray
                Department of Psychology
                Institute of Psychiatry
                De Crespigny Park Denmark Hill 
                London SE5 8AF England
		spjtjds@ucl.ac.uk
		jgray@ux.psych.lon.ac.uk

KEYWORDS: Cholinergic system, cerebral ischaemia, cognitive function,
          neural grafts.

ABSTRACT: Cognitive deficits were produced in rats using different
methods of damaging the brain: chronic ingestion of alcohol, causing
widespread damage to diffuse cholinergic and aminergic projection
systems; lesions (by local injection of the excitotoxins, ibotenate,
quisqualate and AMPA) to the nuclei of origin of the forebrain
cholinergic projection system (FCPS), which innervates the neocortex
and hippocampal formation; transient cerebral ischaemia, producing
focal damage, especially in the CA1 pyramidal cells of the dorsal
hippocampus; and lesions (by local injection of the neurotoxin,
colchicine) to the granule cells of the dentrate gyrus. Following
chronic alcohol or lesions of the FCPS, transplants of cholinergically
rich fetal brain tissue into the terminal areas (neocortex or
hippocampus) restored performance almost to control levels, with a
time-course consistent with growth of the transplants and integration
with host tissue; transplants of cholinergically poor fetal tissue
(hippocampus) were without effect, as were transplants of
cholinergically rich tissue into the region containing the nuclei of
origin of the FCPS. Grafts of primary cells enriched in glia and
cultured neuroblastoma cells into the terminal areas of the FCPS were
equally effective, suggesting that there are multiple mechanisms by
which neural transplants can restore cognitive function following
diffuse cholinergic damage.  In contrast, after ischaemia- or
neurotoxin-induced damage to CA1 or dentate granule cells respectively,
cholinergically rich fetal transplants into the damaged hippocampal
formation were ineffective in restoring performance. However, after
ischaemic damage, performance was restored by suspension grafts of CA1
cells but not by transplants containing CA3 pyramidal cells or granule
cells; and after colchicine damage, performance was restored by solid
grafts containing granule but not CA1 pyramidal cells. Furthermore,
electrophysiological evidence has demonstrated functional, graft
type-specific host-graft fuctional neuronal connectivity. Thus,
restoration of cognitive function by neural transplants is possible
after damage to either diffuse (cholinergic) or point-to-point
(intrahippocampal) forebrain systems, but the transplant must be
appropriate to the damage to be repaired. Since the different types of
brain damage studies provide partial analogues of human alcoholic
dementia, Alzheimer's disease and heart attack, these results are
encouraging with regard to the eventual application of neural
transplant surgery to the treatment of cognitive deficits in humans.
-----------------------------------------------------------------------
2.
        FETAL BRAIN TISSUE GRAFTS AS THERAPY FOR BRAIN DYSFUNCTIONS:
                SOME PRACTICAL AND THEORETICAL ISSUES

                Donald G. Stein & Marylou M. Glasier
                Laboratory of Brain Research and CNS Plasticity
                Institute of Animal Behavior
                Rutgers University
                Newark, NJ 07102
                stein@draco.rutgers.edu

KEYWORDS: Brain damage; functional recovery; grafts; neural grafts;
          neural transplants

ABSTRACT: Grafting embryonic neural tissue into the brains of adult
patients is currently being used to treat Parkinson's disease and is
being given serious consideration as therapy for a variety of other
degenerative and traumatic disorders. This target article evaluates the
use of transplants to promote recovery from brain injury and highlights
the kinds of questions and problems that must be addressed before this
form of therapy is routinely applied. It has been argued that neural
transplantation can promote functional recovery through the replacement
of damaged nerve cells, the reestablishment of specific nerve pathways
lost as a result of injury, the release of specific neurotransmitters,
or the production of factors that promote neuronal growth. The latter
two mechanisms, which need not rely on anatomical connections to the
host brain, are open to examination through nonsurgical, less intrusive
therapy. Subjective judgments in selecting which patients will receive
grafts and in assessing the outcome of graft therapy make evaluation of
the procedure methodologically difficult. In addition, little long-term
assessment of transplant efficacy and effect has been done in nonhuman
primates. Carefully controlled human studies, with multiple testing
paradigms, are also needed to establish the efficacy of transplant
therapy.
-----------------------------------------------------------------------
3.
        GENE REPLACEMENT THERAPY IN THE CENTRAL NERVOUS SYSTEM:
    VIRAL VECTOR MEDIATED THERAPY OF GLOBAL NEURODEGENERATIVE DISEASE

        Edward A.Neuwelt, Michael A. Pagel, Leslie L. Muldoon
                Oregon Health Sciences University,
                Portland OR 97201

                Alred Geller
                Children's Hospital
                Boston, MA 02115

KEYWORDS: adenovirus; blood-brain barrier; gene therapy; herpes
          virus; pHexosaminidase

ABSTRACT: This target article describes the current state of global
gene replacement in the brain through the use of viral vectors and it
assesses possible solutions to some of the many problems inherent in
gene therapy for the central nervous system (CNS). Gene replacement
therapy is a way to generate normal human proteins in deficient cells,
making cures possible for certain genetically inherited enzyme
deficiences, metabolic diseases, and cancers. The two major issues to
be addressed are the delivery of genetic material to the brain and the
expression of recombinant genetic material in CNS target cells. Focal
inoculation of recombinant virions or other genetic vectors has
limitations when there is global brain disease. A new
blood-brain-barrier (BBB) disruption technique, in which hypertonic
mannitol transiently shrinks the BBB endothelium, allows the passage of
high molecular weight compounds and even viruses. CNS gene therapy will
require a viral vector system that allows long-term, nontoxic gene
expression in neurons or glial cells. Retroviral vectors have
limitations in CNS gene replacement, although they are suitable for
expressing recombinant genes in intracerebral grafts, or toxic genes in
brain tumors. Mutant neurotropic viruses with reduced neurotoxicity
(e.g., defective herpes simplex virus type 1 [HSV-1], the HSV-1
amplicon vector system we have developed, or adenovirus mutants) have
potential for direct treatment of neurons. Injecting these vectors into
rodent brains can lead to the stable expression of foreign genetic
material in postmitotic neuronal cells. We discuss our BBB disruption
delivery technique, our defective HSV-1 aplicon vector system, and our
feline model for the neuronal lysosomal storage disorder
Gm2-gangliosidosis (Sandhoff disease), which may prove to be a useful
model system for CNS gene therapy.
----------------------------------------------------------------------
To help you decide whether you would be an appropriate commentator for
this article, electronic drafts are retrievable by anonymous ftp from
princeton.edu according to the instructions below (the filenames are
bbs.sinden bbs.stein and bbs.neuwelt). Please do not prepare a
commentary on these drafts. Just let us know, after having inspected them,
what relevant expertise you feel you would bring to bear on what aspect
of each article.
-------------------------------------------------------------
   To retrieve a file by ftp from a Unix/Internet site, type either:
ftp princeton.edu
   or
ftp 128.112.128.1
   When you are asked for your login, type:
anonymous
   Enter password as per instructions (make sure to include the specified @),
   and then change directories with:
cd /pub/harnad/BBS
   To show the available files, type:
ls
   Next, retrieve the file you want with (for example):
get bbs.sinden
   When you have the file(s) you want, type:
quit
   In case of doubt or difficulty, consult your system manager.
   A more elaborate version of these instructions for the U.K. is
   available on request (thanks to Brian Josephson).

  The files are also retrievable through archie, gopher, veronica, etc.
----------
Where the above procedures are not available (e.g. from Bitnet or other
networks), there are two fileservers:
ftpmail@decwrl.dec.com
       and
bitftp@pucc.bitnet
that will do the transfer for you. To one or the
other of them, send the following one line message:

help

for instructions (which will be similar to the above, but will be in
the form of a series of lines in an email message that ftpmail or
bitftp will then execute for you).
-------------------------------------------------------------

From owner-chromosomes@net.bio.net Mon Dec 06 22:00:00 1993
Path: biosci!CS.Arizona.EDU!organpipe.uug.arizona.edu!uunet!cs.utexas.edu!howland.reston.ans.net!usenet.ins.cwru.edu!news.ecn.bgu.edu!anaxagoras.ils.nwu.edu!news.acns.nwu.edu!raven.alaska.edu!netnews.nwnet.net!news.u.washington.edu!carson.u.washington.edu!bethp
From: bethp@carson.u.washington.edu (Beth Plotkin)
Newsgroups: bionet.genome.chromosomes
Subject: Genetic Diversity???
Summary: Genetic Diversity???
Keywords: genetic diversity
Message-ID: <2e1dgk$k9j@news.u.washington.edu>
Date: 7 Dec 93 08:05:40 GMT
Organization: University of Washington
Lines: 23
NNTP-Posting-Host: carson.u.washington.edu

Here's a perhaps naive question from a non-genetics-type person:

I know that incest has long been taboo, since the likelihood
of genetic problems in off-spring increases in these situations.
Is it preferable, therefore, for two parents to be as diverse
genetically as possible (in a given species)?

Some breeds of dogs, for example, have strange dispositions...
yet many "mutts" often seem to be well-disposed.  When you
constantly breed for certain traits through the generations,
aren't there apt to be more "problems" as well?

If this were true with people, "inter-racial" marriages should
be encouraged to prevent in-breeding.  

Unlike dogs, where traits are selected by people, our traits stem 
from our nomadic wanderings, do they not?  We're all Homo
sapiens, but blue eyes, brown skin were all preferred adaptations for
different climates?  Such racial purists as Adolph Hitler were
complete oblivious!

Sorry if this is an ignorant or offensive question to anyone.
I don't read this net but am curious about this subject.

From owner-chromosomes@net.bio.net Mon Dec 06 22:00:00 1993
Path: biosci!JUDY.ENG.UCI.EDU!liang
From: liang@JUDY.ENG.UCI.EDU (liang)
Newsgroups: bionet.genome.chromosomes
Subject: CHINESES_BIOTECH_NET_FOUNDED
Message-ID: <9312061945.AA20474@judy.eng.uci.edu>
Date: 6 Dec 93 19:45:40 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 12


CBNet (Chinese Biotechnology Network) is a non-profit organization composed of
professionals in biological, chemical, medical sciences, engineering
and related fields.  The CBNet sponsors the Chinese Biotechnology Internet
Forum (CBIF) newsletter. To subscribe CBIF, please send an email to
Listserv@UCSD.Edu with the message body: Add CB-Net.

          
       




From owner-chromosomes@net.bio.net Mon Dec 06 22:00:00 1993
Path: biosci!JUDY.ENG.UCI.EDU!liang
From: liang@JUDY.ENG.UCI.EDU (liang)
Newsgroups: bionet.genome.chromosomes
Subject: CHINESES_BIOTECH_NET_FOUNDED
Message-ID: <9312060500.AA19369@judy.eng.uci.edu>
Date: 6 Dec 93 05:00:44 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 12


CBNet (Chinese Biotechnology Network) is a non-profit organization composed of
professionals in biological, chemical, medical sciences, engineering
and related fields.  The CBNet sponsors the Chinese Biotechnology Internet
Forum (CBIF) newsletter. To subscribe CBIF, please send an email to
Listserv@UCSD.Edu with the message body: Add CB-Net.

          
       




From owner-chromosomes@net.bio.net Mon Dec 06 22:00:00 1993
Path: biosci!MENDEL.LLNL.GOV!greg
From: greg@MENDEL.LLNL.GOV
Newsgroups: bionet.genome.chromosomes
Subject: Human Chromosome Ideograms
Message-ID: <9312071713.AA02683@mendel.llnl.gov>
Date: 7 Dec 93 17:13:56 GMT
Sender: daemon@net.bio.net
Reply-To: Greg Lennon <greg@mendel.llnl.gov>
Distribution: bionet
Lines: 26


As scooped off human-genome-program@net.bio.net,
as posted by Uta Francke <MH.UTA@Forsythe.Stanford.EDU> :


TO: Human Cytogeneticists and Genome Mappers

Human chromosome ideograms that depict 850 bands, numbered in
agreement with ISCN (1981) nomenclature but based on actual
measurements of band sizes and differentiated by five shades of
staining intensity, have been digitized using ADOBE graphics
software.  These ideograms  provide for more accurate estimates of
distances within chromosome arms, DNA content of chromosome bands
and correlation between cytohgenetic, molecular and genetic linkage
maps than the standard ISCN ideograms.

Reference: Francke, Uta (1994) Digitized and differentially shaded
human chromosome ideograms for genomic application. Cytogenet. Cell
Genet 65:206-218

Diskettes for Mac or IBM compatible computers are available from the
publisher of CCG who has all the rights.

For information: Editorial office, Cytogenetics and Cell Genetics,
Dr. Harold P. Klinger, Phone: 718-430-2451  FAX: 718-430-2454


From owner-chromosomes@net.bio.net Wed Dec 08 22:00:00 1993
Path: biosci!HELIX.MGH.HARVARD.EDU!HAINES
From: HAINES@HELIX.MGH.HARVARD.EDU ("Jonathan L. Haines")
Newsgroups: bionet.genome.chromosomes
Subject: (none)
Message-ID: <01H693TB88B68WY03F@HELIX.MGH.HARVARD.EDU>
Date: 9 Dec 93 03:09:25 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 152


                -    COURSE ANNOUNCEMENT      -        


          GENETIC ANALYSIS METHODS FOR MEDICAL RESEARCHERS   

Description:  

A comprehensive four day course directed toward physician
scientists and/or other medical researchers that will introduce
them to state-of-the-art approaches for mapping human inherited
disorders of both a monogenic and polygenic nature, such as
cancer syndromes, multiple sclerosis, etc.  The overall
focus of the course is on the development of a broad-based
knowledge of the resources available through the Human Genome
Initiative, and overall project decision making, rather than the
mechanics of specific techniques.  The specific goals are:  

1.   To outline and instruct participants in detail about the
necessary steps and procedures used in ascertaining and
collecting pedigree data and family history information.  These
processes include the use of family history questionnaires,
computer management systems, simulation of data to determine
linkage power, designs for clinical sampling schemes, and the
actual sampling and subsequent cataloguing and storing of
pedigree DNA for study. 


2.   To discuss in detail the methodologies for using the Index
Marker Maps generated by the efforts of the Human
Genome Initiative.  This will include a broad understanding of
PCR technology and its use for genotyping dinucleotide or other
simple sequence length polymorphisms.  It will also include a
discussion of statistical analytical methods such as lod scores
and the examination of affected relative pairs.  Emphasis will be
on working examples as well as the basic theory behind these
genetic mapping methodologies rather than intensive computational
exercises.  Information will be available about the computational
resources necessary to undertake such a study and how to obtain
them.  

3.   To educate participants on the general interpretation of
linkage results.  Discussions will include an overview of
positional cloning strategies, refinement of the preliminary
linkage data, examination of heterogeneity, physical mapping,
cDNA analysis, exon amplification etc.  This course will not
include any bench or "wet" laboratory experience.

4.   To incorporate discussion of the participant's individual
research interests.  Participants will be encouraged to bring
preliminary information and/or data for both formal and informal
group discussion and instructor consultation.  Course
participants will be polled prior to the course about their
particular needs and interests and their own motivations for
taking the course.  Extensive efforts will be made to incorporate
the suggested topics of participants.  



Faculty: 


Organizers:         

Margaret A. Pericak-Vance, Ph.D.                                 
Dept. of Medicine
Division of Neurology 
Duke University Medical Center                

Jonathan L. Haines, Ph.D.                     
Molecular Neurogenetics Unit
Massachusetts General Hospital      
 

Instructors:        

Jeffrey Murray, M.D.                         
Division of Medical Genetics
University of Iowa Hospitals                  

Marcy C. Speer, Ph.D.                         
Dept. of Medicine
Division of Neurology
Duke University Medical Center                

Arthur S. Aylsworth, M.D.                     
Chief, Division of Genetics and Metabolism,
Dept. of Pediatrics
University of North Carolina at Chapel Hill   

David Goldgar, Ph.D.                         
Dept. of Medical Informatics
University of Utah  

Deborah Meyers, Ph.D.
Dept. of Medicine
School of Medicine
Johns Hopkins University


The broad-based faculty has extensive expertise in genetic
epidemiology, positional cloning, reference marker mapping,
laboratory techniques, clinical diagnosis and family collection. 
Faculty will be available throughout the course for informal
discussions.   


Location:           The R. David Thomas Center                   

                    The Fuqua School of Business                 

                    Duke University                          
                    Durham, NC  


The Thomas center, by offering both in-house accommodations and
meals, promotes maximum interactions, both formal and informal,
between participants.  Most faculty will be staying on-site for the
duration of the course.

Date:               May 15 through May 18, 1994  



Participation:  

Individuals with an M.D. or Ph.D. and a specific disease-related
interest are encouraged to apply but participation will be limited
to a total of 35 individuals.  Up to five scholarships will be
available for M.D. and/or Ph.D. students and fellows.  Women and
minorities are specifically encouraged to apply.  The deadline for receipt
of completed application forms is February 21, 1994.


For more information about registration fees, course
requirements, etc:       


Write:              Genetic Methods Course                       

                    c/o Dr. Margaret Pericak-Vance               

                    Division of Neurology, Box 2900              

                    Duke University Medical Center               

                    Durham, NC  27710       
OR:

E-Mail:             genclass@genemap.mc.duke.edu    

In any correspondence, please include a postal address.

From owner-chromosomes@net.bio.net Wed Dec 08 22:00:00 1993
Path: biosci!bcm!cs.utexas.edu!uunet!biosci!JUDY.ENG.UCI.EDU!liang
From: liang@JUDY.ENG.UCI.EDU (liang)
Newsgroups: bionet.genome.chromosomes
Subject: CHINESES_BIOTECH_NET_FOUNDED
Message-ID: <9312061945.AA20474@judy.eng.uci.edu>
Date: 6 Dec 93 19:45:40 GMT
Sender: daemon@net.bio.net
Distribution: bionet
Lines: 9


CBNet (Chinese Biotechnology Network) is a non-profit organization composed of
professionals in biological, chemical, medical sciences, engineering
and related fields.  The CBNet sponsors the Chinese Biotechnology Internet
Forum (CBIF) newsletter. To subscribe CBIF, please send an email to
Listserv@UCSD.Edu with the message body: Add CB-Net.

          
       

From owner-chromosomes@net.bio.net Thu Dec 09 22:00:00 1993
Path: biosci!NET.BIO.NET!kristoff
From: kristoff@NET.BIO.NET (David Kristofferson)
Newsgroups: bionet.genome.chromosomes
Subject: IMPORTANT BIOSCI INFORMATION
Message-ID: <9312101000.AA28283@net.bio.net>
Date: 10 Dec 93 10:00:04 GMT
Sender: kristoff@net.bio.net
Distribution: bionet
Lines: 244


Three important items follow: BIOSCI archive searching by e-mail, the
BIOSCI FAQ, and the BIOSCI User Address Directory form.  If you have
not yet listed yourself in our e-mail address directory, please take a
few minutes to complete and return the form below.  If your address
information has changed since you listed yourself, please send us an
updated form.

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				kristoff@net.bio.net



	  **** SEARCHING BIOSCI ARCHIVES WITH WAISMAIL ****

E-mail users can search the BIOSCI archives by using our waismail
e-mail server.  For instructions send the message

help

to waismail@net.bio.net.  Leave the Subject: line blank.  Other
methods of searching the archives via WAIS and gopher are described in
the BIOSCI FAQ.


       **** BIOSCI FREQUENTLY ASKED QUESTIONS (FAQ) SHEET ****

New users of BIOSCI/bionet may want to read the "Frequently Asked
Questions" or "FAQ" sheet for BIOSCI.  The FAQ provides details on how
to participate in these forums and is available for anonymous FTP from
net.bio.net [134.172.2.69] in pub/BIOSCI/biosci.FAQ or for retrieval
by gopher to net.bio.net, port 70.  It may also be requested by
sending e-mail to biosci@net.bio.net (use plain English for your
request).  The FAQ is also posted on the first of each month to the
newsgroup BIONEWS/bionet.announce immediately following the posting of
the BIOSCI information sheet.


	       **** BIOSCI USER ADDRESS DIRECTORY ****

Please take this opportunity to add your name and address information
to the BIOSCI User Address Database if you have not already done so.

Below is the address form that we would like each reader of the
BIOSCI/bionet newsgroups to complete and return if you would like to
be listed in our database.  The database serves as a directory that
enables biologists, who are currently using (or even just reading) the
BIOSCI newsgroups, to look up e-mail addresses and other information
about our users.

The address database is reindexed nightly for WAIS and waismail access
(waismail is our WAIS e-mail server, more below) and will also be
available for access via other gopher sites if they wish to permit it.
The raw unindexed data is available for FTP from net.bio.net and is
atomized sufficiently to allow import into your local RDBMS should you
so desire.

Please carefully follow the instructions for completing the form
below and return it to either of the following two addresses
(whichever is more convenient for you).  Thanks in advance for taking
the time to complete and return the form.

Addresses for returning forms         Location        Network
-----------------------------         --------        -------
biovote@net.bio.net                   U.S.A.          Internet/BITNET
biovote@daresbury.ac.uk               U.K.            JANET


	     MAKING SURE THAT YOUR INFORMATION IS CURRENT

This notice will be mailed bimonthly to each newsgroup.  You should
check our WAIS source or waismail e-mail server from time-to-time to
see if your address information is still up-to-date.  Send the message

help

to waismail@net.bio.net for instructions on using waismail.  Leave the
Subject: line in your message blank.


		  Using Gopher to complete the form
                  ---------------------------------

If you don't want to use a text editor, you can also use Dan
Jacobson's gopher site to fill out the address database form as
follows.  Otherwise skip this section on gopher and proceed to the
instructions for filling out the form below.

> To add yourself to the database just point your
> gopher client at merlot.gdb.org and select the following:
> 
> -->  15. Searching For Biologists/
> 
>  -->  9.  E-mail Addresses of Biosci-Bionet Users/
> 
>   -->  1.  Add (or Correct) Your Address to the BIOSCI User Address
> Data..
> 
> 
> And fill out the form.

or Rob Harper's gopher site in Europe as follows:

> Europeans can point their gopher client at gopher.csc.fi and add their
> information to the database. All entries will be mailed directly to
> Dave for incorporation in a wais source.
> 
> The path to the questionare is as follows.
> 
>    ---> 10. Finnish EMBnet BioBox/
> 
>         ---> 8.  FAQ Files/
> 
>                               FAQ Files
> 
>       1.  EMBnet: Information.
>       2.  EMBnet: Internet resources guide.
>       3.  A Biologist's Guide to Internet Resources/
>       4.  All FAQs (Frequently Asked Questions) Searches and Archives/
>   --->5.  Bionauts Address Database (questionaire) <TEL>


	    IMPORTANT INSTRUCTIONS - PLEASE READ CAREFULLY

Please enter all responses after the : on each line, leaving one (1)
blank space after the : (i.e., before the start of your text).

Please do NOT extend your responses past the end of each line (80
characters) or alter any of the field identifiers such as "first name: ". 
Several lines are provided at the end of the form for comments, but,
please adhere to the line length restriction.

On the date: line, please enter the date in the DD-MM-YY format, e.g.,
05-05-93 for 5 May 1993.  This line will tell others when the
information was last updated.  Please be sure to include the 0's for
single digit days or months, e.g., 05-05-93, not 5-5-93.

Note that the "e-mail network: " line below is for specifying, e.g.,
"Internet," "BITNET," "EARN," "JANET," or whatever other network that
your computer may be on.

If you are uncertain about any field, please feel free to leave it
blank, but please DO NOT DELETE the field identifier from the form!

In the first field below, "New information or Update ...", please
enter "N" if this is the first time that you have registered in the
directory or "U" if you are correcting a listing that you sent to us
previously.

The comment: lines may be used for anything that you like but PLEASE
DO NOT DELETE THEM FROM THE FORM OR ALTER THEM.  One suggested use is
to list the names of the newsgroups in which you participate.  Please
use the MAILING LIST name (see below - the latest version of the list
can be requested from biosci@net.bio.net) instead of the USENET name
even if you don't participate by e-mail.  WAIS might get confused by
the periods in the USENET names.  This allows one to retrieve via WAIS
or waismail the list of participants in a particular group.

For example:

comment: ARABIDOPSIS PLANT-BIOLOGY BIONEWS

On the comment: lines
use these names below ---- NOT the USENET names below

MAILING LIST NAME          USENET Newsgroup Name
-----------------          ---------------------
ACEDB-SOFT                 bionet.software.acedb
AGEING                     bionet.molbio.ageing
AGROFORESTRY               bionet.agroforestry
ARABIDOPSIS                bionet.genome.arabidopsis
BIOFORUM                   bionet.general
BIO-INFORMATION-THEORY     bionet.info-theory
BIONAUTS                   bionet.users.addresses
BIONEWS                    bionet.announce
BIO-JOURNALS               bionet.journals.contents
BIO-MATRIX                 bionet.molbio.bio-matrix
BIO-SOFTWARE               bionet.software
CHROMOSOMES                bionet.genome.chromosomes
COMPUTATIONAL-BIOLOGY      bionet.biology.computational
DROSOPHILA                 bionet.drosophila
EMBL-DATABANK              bionet.molbio.embldatabank
EMPLOYMENT                 bionet.jobs
GDB                        bionet.molbio.gdb
GENBANK-BB                 bionet.molbio.genbank
GENETIC-LINKAGE            bionet.molbio.gene-linkage
HIV-MOLECULAR-BIOLOGY      bionet.molbio.hiv
HUMAN-GENOME-PROGRAM       bionet.molbio.genome-program
IMMUNOLOGY                 bionet.immunology
INFO-GCG                   bionet.software.gcg
JOURNAL-NOTES              bionet.journals.note
METHODS-AND-REAGENTS       bionet.molbio.methds-reagnts
MOLECULAR-EVOLUTION        bionet.molbio.evolution
NEUROSCIENCE               bionet.neuroscience
N2-FIXATION                bionet.biology.n2-fixation
PHOTOSYNTHESIS             bionet.photosynthesis
PLANT-BIOLOGY              bionet.plants
POPULATION-BIOLOGY         bionet.population-bio
PROTEIN-ANALYSIS           bionet.molbio.proteins
PROTEIN-CRYSTALLOGRAPHY    bionet.xtallography
RAPD                       bionet.molbio.rapd
SCIENCE-RESOURCES          bionet.sci-resources
TROPICAL-BIOLOGY           bionet.biology.tropical
VIROLOGY                   bionet.virology
WOMEN-IN-BIOLOGY           bionet.women-in-bio
YEAST                      bionet.molbio.yeast

Listing newsgroups on the comment: line is optional, of course.

Thanks again for your cooperation!



--------------- please cut here and return portion below ---------------

New information or Update to old record (enter N or U): 
date (DD-MM-YY): 
first name: 
middle initial: 
family name: 
job title: 
e-mail address: 
e-mail network: 
phone number: 
FAX number: 
institution: 
address1: 
address2: 
address3: 
city: 
state/province: 
country: 
postal code: 
research interest: 
research interest: 
comment: 
comment: 
comment: 
comment: 
comment: 

From owner-chromosomes@net.bio.net Tue Dec 14 22:00:00 1993
Path: biosci!GALAXY.GOV.BC.CA!PMACLEOD
From: PMACLEOD@GALAXY.GOV.BC.CA (Patrick Macleod 727-4461)
Newsgroups: bionet.genome.chromosomes
Subject: Human chromosome 14 del(q32.1)
Date: 14 Dec 1993 17:38:37 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 8
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <01H6H5X4308AB3X84S@gems.gov.bc.ca>
NNTP-Posting-Host: net.bio.net

    I wish to contact anyone who has a case(s) of this condition and who is 
    willing to share some of their experience with the natural history with 
    the parents of our local case. 
    Thank you
    PMacleod@galaxy.gov.bc.ca
    



From owner-chromosomes@net.bio.net Wed Dec 15 22:00:00 1993
Newsgroups: bionet.genome.chromosomes
Subject: Manic Depression Gene
From: pete.dixon@canrem.com (Pete Dixon)
Path: biosci!bcm!cs.utexas.edu!uunet!news2.uunet.ca!uunet.ca!uunet.ca!portnoy!canrem.com!pete.dixon
Distribution: world
Message-ID: <60.617.5254.0N18E77F@canrem.com>
Date: Thu, 16 Dec 93 00:27:00 -0400
Organization: CRS Online  (Toronto, Ontario)
Lines: 19

At a recent meeting of my Manic Depressive group a video was shown where they
talked about how a causal gene/gene set had been identified on chromosome 11.
The identification was confirmed by testing affected and non-affected family
members among the Amish and other gene mapping-friendly groups.

The strong implication to me was that there was now a genetic marker test for
this gene. If there is can someone direct to sources, costs, availability
information about these tests.

Even if the cost was in the 100's of dollars it would be cheap in relation to
the damage last/mis-diagnosis can cause. FYI, most manics report 11 years and a
series of mis-diagnoses before a Manic Depression conclusion was reached.
That's a lot of talk therapy to sit through to find out one's problem is
biochemical in origin. Not to mention the effect of those un-needed
psychotropic drugs.

Pete Dixon
Kitchener, Ontario
Canada

From owner-chromosomes@net.bio.net Wed Dec 15 22:00:00 1993
Newsgroups: bionet.genome.chromosomes
Path: biosci!bcm!cs.utexas.edu!uunet!pipex!uknet!doc.ic.ac.uk!mrccrc!crc.ac.uk!dcurtis
From: dcurtis@crc.ac.uk (Dr. David Curtis)
Subject: Re: Manic Depression Gene
Message-ID: <1993Dec16.164403.11331@crc.ac.uk>
Sender: news@crc.ac.uk
Nntp-Posting-Host: tin
Reply-To: dcurtis@crc.ac.uk (Dr. David Curtis)
Organization: MRC Human Genome Mapping Project Resource Centre, Harrow, UK
References:  <60.617.5254.0N18E77F@canrem.com>
Date: Thu, 16 Dec 1993 16:44:03 GMT
Lines: 29

In article <60.617.5254.0N18E77F@canrem.com>, pete.dixon@canrem.com (Pete Dixon) writes:
> At a recent meeting of my Manic Depressive group a video was shown where they
> talked about how a causal gene/gene set had been identified on chromosome 11.
> The identification was confirmed by testing affected and non-affected family
> members among the Amish and other gene mapping-friendly groups.
> 
> The strong implication to me was that there was now a genetic marker test for
> this gene. If there is can someone direct to sources, costs, availability
> information about these tests.

We're _very_ far from such a situation. The Amish result may well have been a false 
positive. There are a few positive association studies suggesting a role for 
mutations in this region leading to manic depression, but just as many negative
ones. Certainly many cases of manic depression are _not_ caused by genes in this region,
so the results of any negative test could be difficult to interpret, certainly
without testing many other members of a family. 

On the other hand, at any time there could be a big breakthrough which could bring
about the possibilities you envisage. We've seen this happen recently with 
Alzheimer's disease (though not to the extent of having simple tests for the majority 
of cases) and there's no reason why manic depression shouldn't be next - we're all
working hard enough at it. It just hasn't happened yet, that's all.

Dave Curtis

Academic Department of Psychiatry,    Janet:       dcurtis@UK.AC.CRC
St. Mary's Hospital,                  Elsewhere:   dcurtis@CRC.AC.UK
Praed Street, London W2.              EARN/Bitnet: dcurtis%CRC@UKACRL
Tel 071-725 1993                      Usenet: ...!mcsun!ukc!mrccrc!D.Curtis

From owner-chromosomes@net.bio.net Sun Dec 19 22:00:00 1993
Path: biosci!daresbury!doc.ic.ac.uk!uknet!pipex!howland.reston.ans.net!paladin.american.edu!constellation!news.uoknor.edu!aardvark.ucs.uoknor.edu!broe
From: broe@aardvark.ucs.uoknor.edu (Bruce Roe)
Newsgroups: bionet.genome.chromosomes
Subject: CEPH-Genethon Map
Date: 19 Dec 1993 08:23 CST
Organization: University of Oklahoma - University Computing Services
Lines: 39
Distribution: world
Message-ID: <19DEC199308234358@aardvark.ucs.uoknor.edu>
NNTP-Posting-Host: 129.15.10.11
Keywords: chromosomes, map, ceph, genethon
News-Software: VAX/VMS VNEWS 1.41    

        From what I gather, second/third had, Cohen's group
had YAC contig maps completed for all the human chromosomes.
This is very exciting news but only the first-generation map.
Much more work is needed to get from here to a sequence ready
map. 
	Hats off to Cohen and co-workers for providing us all 
with this very useful and much needed data.  What a great present
to be given for this holiday season.  On to the next stages of 
finer mapping and large scale sequencing!!

The following was posted to bionet.general and I'm including it
here for those who missed it:

> The data of the ceph-genethon-map (Nature paper :
> "A first-generation physical map of the human genome"
> D. Cohen, I. Chumakov & J. Weissenbach )
> can be accessed by :
>
>        ftp anonymous : ceph-genethon-map.genethon.fr
>                dir  pub/ceph-genethon-map
>
>        mail to : ceph-genethon-map@genethon.fr
>
>        gopher : gopher.genethon.fr
>                -> Genethon Data
>                        -> Pmap
>
>        WWW : http://www.genethon.fr/genethon_en.html
>
> -------------------------------------------------------------
> Patricia RODRIGUEZ-TOME       Genethon
> Internet : pat@genethon.fr
> -------------------------------------------------------------

Cheers.......bruce
  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
 \  Bruce A. Roe               Professor of Chemistry and Biochemistry /
 /  University of Oklahoma     INTERNET: BROE@aardvark.ucs.uoknor.edu  \
  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  - - -

From owner-chromosomes@net.bio.net Wed Dec 22 22:00:00 1993
Path: biosci!daresbury!doc.ic.ac.uk!agate!howland.reston.ans.net!nctuccca.edu.tw!TWNMOE10.Edu.TW!YMMCS010
From: YMMCS010@TWNMOE10.Edu.TW
Newsgroups: bionet.genome.chromosomes
Subject: Fluorescent in situ hybridization
Date: Thu, 23 Dec 93 17:48:04 GMT
Organization: MOE Computer Center, Taiwan
Lines: 8
Message-ID: <16CADFA54.YMMCS010@TWNMOE10.Edu.TW>
NNTP-Posting-Host: twnmoe10.edu.tw
Keywords: FISH
X-Newsreader: NNR/VM S_1.3.2

Hello, could someone provide me the information whether genomic DNA with its ve
ctor, the lambda phage, could be used as the probe for FISH in genomic mapping?
Because I have tried for several times but all failed. Please e-mail me to
YMMCS010@TWNMOE10.EDU.TW. Thanks.
 
Frank
 
 

From owner-chromosomes@net.bio.net Thu Dec 23 22:00:00 1993
Path: biosci!CS.Arizona.EDU!organpipe.uug.arizona.edu!uunet!nctuccca.edu.tw!TWNMOE10.Edu.TW!YMMCS023
From: YMMCS023@TWNMOE10.Edu.TW
Newsgroups: bionet.genome.chromosomes
Subject: CAG trinucleotide repeat
Date: Sat, 25 Dec 93 04:05:02 GMT
Organization: MOE Computer Center, Taiwan
Lines: 9
Message-ID: <16CAF396E.YMMCS023@TWNMOE10.Edu.TW>
NNTP-Posting-Host: twnmoe10.edu.tw
X-Newsreader: NNR/VM S_1.3.2

Are there any groups interested in (or working on) cDNA with trinucleotide repe
at? I am a clinical psychiatrist and interested in the genetics of psychiatric
disorders, especially schizophrenia, bipolar disorder and Alzheimer's disease.
I guess there is a chance inheritable psychiatric diseases are caused by trinuc
leotide repeat expansion. Will I be right? What's the rationale to verify this
idea? Anybody offering relevant information will be highly appreciated.
 
Horng
e-mail: ymmcs023@twnmoe10.edu.tw

From owner-chromosomes@net.bio.net Thu Dec 23 22:00:00 1993
Path: biosci!CS.Arizona.EDU!organpipe.uug.arizona.edu!uunet!pipex!doc.ic.ac.uk!daresbury!bioftp.unibas.ch!embl-heidelberg.de!rice
From: rice@embl-heidelberg.de (Peter Rice)
Newsgroups: bionet.genome.chromosomes
Subject: Re: CAG trinucleotide repeat
Message-ID: <1993Dec24.225853.146730@embl-heidelberg.de>
Date: 24 Dec 93 22:58:53 +0100
References: <16CAF396E.YMMCS023@TWNMOE10.Edu.TW>
Organization: EMBL, European Molecular Biology Laboratory
Lines: 17

In article <16CAF396E.YMMCS023@TWNMOE10.Edu.TW>, YMMCS023@TWNMOE10.Edu.TW
writes:
> I guess there is a chance inheritable psychiatric diseases are caused by trinuc
> leotide repeat expansion. Will I be right?

If Huntingdon's Chorea or Fragile X Syndrome count as psychiatric disorders,
then you are right already.

(Or perhaps it takes a dinucleotide repeat to make someone truly GAGA :-)

 -----------------------------------------------------------------------------
 Peter Rice, EMBL                             | Post: Computer Group
                                              |       European Molecular
 Internet:    Peter.Rice@EMBL-Heidelberg.DE   |            Biology Laboratory
                                              |       Postfach 10-2209
 Phone:   +49-6221-387247                     |       69012 Heidelberg
 Fax:     +49-6221-387306                     |       Germany

From owner-chromosomes@net.bio.net Sun Dec 26 22:00:00 1993
Path: biosci!rutgers!cs.utexas.edu!howland.reston.ans.net!nctuccca.edu.tw!TWNMOE10.Edu.TW!YMMCS023
From: YMMCS023@TWNMOE10.Edu.TW
Newsgroups: bionet.genome.chromosomes
Subject: How to compare a strech of sequence with genebank
Message-ID: <16CB21457.YMMCS023@TWNMOE10.Edu.TW>
Date: 28 Dec 93 01:26:47 GMT
Organization: MOE Computer Center, Taiwan
Lines: 11
NNTP-Posting-Host: twnmoe10.edu.tw
X-Newsreader: NNR/VM S_1.3.2

I got some sequences from human fetal brain cDNA. Where could I compare these
uences with DNA bank (requiring no specific password) on internet to see if I h
ave got something new or something old. Any information will be highly appresci
ated.
 
Sincerely
 
CHEN-JEE HORNG, M.D.
DEPARTMENT OF PSYCHIATRY
VETERANS GENERAL HOSPITAL-TAIPEI
TAIPEI, TAIWAN, R.O.C.

From owner-chromosomes@net.bio.net Mon Dec 27 22:00:00 1993
Path: biosci!rutgers!uwm.edu!cs.utexas.edu!howland.reston.ans.net!nctuccca.edu.tw!TWNMOE10.Edu.TW!YMMCS023
From: YMMCS023@TWNMOE10.Edu.TW
Newsgroups: bionet.genome.chromosomes
Subject: Comparing DNA sequence in foreign host
Message-ID: <16CB211153.YMMCS023@TWNMOE10.Edu.TW>
Date: 28 Dec 93 19:26:11 GMT
Organization: MOE Computer Center, Taiwan
Lines: 61
NNTP-Posting-Host: twnmoe10.edu.tw
X-Newsreader: NNR/VM S_1.3.2

I know some kind persone has mailed me rich information. I am sorry I lost it b
efore reading it, and I don't remember the name and address of the kind person.
 
I got some sequences from human fetal brain cDNA. Where could I compare these
uences with DNA bank (requiring no specific password) on internet to see if I h
ave got something new or something old. Any information will be highly appresci
ated.
 
Sincerely
 
CHEN-JEE HORNG, M.D.
DEPARTMENT OF PSYCHIATRY
VETERANS GENERAL HOSPITAL-TAIPEI
TAIPEI, TAIWAN, R.O.C.
========================================================================
From: YMMCS023@TWNMOE10.Edu.TW
Path: TWNMOE10.Edu.TW!YMMCS023
Newsgroups: bionet.molbio.bio-matrix
Subject: compare DNA sequence on internet
Message-ID: <16CB21B51.YMMCS023@TWNMOE10.Edu.TW>
Date: Tue, 28 Dec 93 01:56:33 GMT
Organization: MOE Computer Center, Taiwan
X-Newsreader: NNR/VM S_1.3.2
 
 
I got some sequences from human fetal brain cDNA. Where could I compare these
uences with DNA bank (requiring no specific password) on internet to see if I h
ave got something new or something old. Any information will be highly appresci
ated.
 
Sincerely
 
CHEN-JEE HORNG, M.D.
DEPARTMENT OF PSYCHIATRY
VETERANS GENERAL HOSPITAL-TAIPEI
TAIPEI, TAIWAN, R.O.C.
 
 
========================================================================
From: YMMCS023@TWNMOE10.Edu.TW
Path: TWNMOE10.Edu.TW!YMMCS023
Newsgroups: bionet.molbio.gdb
Subject: compare DNA sequence on anonymous DNA bank host
Message-ID: <16CB21D4A.YMMCS023@TWNMOE10.Edu.TW>
Date: Tue, 28 Dec 93 02:04:58 GMT
Organization: MOE Computer Center, Taiwan
X-Newsreader: NNR/VM S_1.3.2
 
I got some sequences from human fetal brain cDNA. Where could I compare these
uences with DNA bank (requiring no specific password) on internet to see if I h
ave got something new or something old. Any information will be highly appresci
ated.
 
Sincerely
 
CHEN-JEE HORNG, M.D.
DEPARTMENT OF PSYCHIATRY
VETERANS GENERAL HOSPITAL-TAIPEI
TAIPEI, TAIWAN, R.O.C.
 
 

